ABSTRACT
Introduction Social protection interventions have the potential to accelerate progress towards global tuberculosis (TB) targets. We piloted a screening and linkage program at four community health centers (HC) to enroll adults seeking TB diagnostic evaluation services into existing government-supported social protection programs in Uganda.
Methods From May-December 2021, health center staff were asked to screen adults being evaluated for TB for eligibility for government-supported social protection programs, and to refer eligible people to a sub-county community development office (CDO) responsible for enrolling community members into government-supported social protection programs. Linkage was facilitated with a transportation reimbursement via mobile money and referral documentation confirming program eligibility. We assessed feasibility using programmatic data and conducted post-intervention surveys to understand experiences with the linkage program.
Results Of 855 people undergoing TB evaluation, 655 (76%) adults met criteria for at least one government-supported social protection program. 25 (4%) of those were not interested in referral; the rest were referred to their local CDO. While 386 (61%) of the 630 participants reported to the CDO seeking social protection enrolment, only 122 (32%) of those were ultimately enrolled into a social protection scheme, representing only 19% (n=655) of those eligible. In participant surveys, among those seeking enrolment at the CDO (n=60; 65% of those surveyed), 46 (77%) were not enrolled into a social protection program. Reasons for non-enrollment were either unknown to the participant (n=25, 54%) or due to operational challenges at the CDO including a lack of human resources or available groups join in the social protection program (n=20, 43%). 61 (63%) survey participants indicated that they would not have sought social protection enrollment without the referral program.
Conclusion Most adults seeking TB diagnostic evaluation are eligible for and interested in obtaining government-supported social protection. We found facilitated linkage from HCs to CDOs offering social protection services to be feasible, however ultimate enrollment into programs was limited. Additional research is needed to identify strategies to improve access to existing social protection programs for eligible TB-affected individuals.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Pan African Clinical Trials Registry (PACTR201906852160014)
Funding Statement
This work was supported by the UCSF-Gladstone Center for AIDS Research Mentored Science Award in HIV/AIDS Research (grant NIH P30 AI027763 Award A120163) Swedish Research Council (Award A134183) and the U.S. National Heart, Lung, and Blood Institute (grant NIH/NHLBI R01AI121144).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the institutional review boards of the University of California San Francisco, San Francisco, CA, USA, Makerere University School of Public Health, Kampala, Uganda and by the Uganda National Council for Science and Technology, Kampala, Uganda, and included a waiver of written informed consent for social protection program referral and access to routinely collected demographic and clinical information among all participants. Verbal consent was obtained for participation in surveys.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
Trial Registration: Pan African Clinical Trials Registry (PACTR201906852160014)
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
